Merck has inaugurated a new Global Capability Centre in Bengaluru, strengthening India’s role in the company’s global technology, research and enterprise operations network.
The new centre marks another expansion by the science and technology company in India, where multinational healthcare and life sciences firms are increasingly building advanced capability hubs. Bengaluru has become a preferred location for such centres because of its deep technology talent pool, mature enterprise ecosystem and growing base of digital health, data science and engineering professionals.
According to the company, the Bengaluru GCC will support global functions across healthcare, life sciences, digital platforms, enterprise solutions and innovation. The centre is expected to contribute to Merck’s international operations by bringing together teams working on technology, analytics, process excellence and business transformation.
Merck already has a significant presence in India across manufacturing, sales, research and shared services. The company has been expanding its India footprint through specialised hubs that support global programmes in healthcare research and development, life sciences, data, enterprise IT and business services. The new centre adds to this network at a time when India is emerging as a strategic base for global pharmaceutical and science-led companies.
The development also reflects the broader growth of global capability centres in India. GCCs have moved beyond traditional back-office functions and are now handling high-value work in product engineering, artificial intelligence, cybersecurity, data analytics, regulatory support, finance, procurement and customer experience. For global enterprises, India-based centres are increasingly becoming engines of innovation rather than only cost-efficient delivery units.
Merck’s India operations have been associated with digital and research-led initiatives, including work on enterprise platforms, data capabilities and healthcare R&D support. The company’s India teams are expected to play a larger role in accelerating innovation, improving operational efficiency and supporting global business functions through technology-led solutions.
The Bengaluru centre is also aligned with the wider trend of life sciences companies investing in digital transformation. Pharmaceutical and healthcare businesses are using data analytics, automation, cloud systems and AI tools to improve drug development, laboratory workflows, manufacturing quality, supply chain efficiency and customer engagement. GCCs are becoming important locations for building and scaling these capabilities.
For India, such investments strengthen the country’s position as a global talent hub for healthcare technology and life sciences operations. Bengaluru, Hyderabad, Pune, Mumbai and Chennai have all attracted large capability centres, but Bengaluru continues to lead because of its established technology ecosystem and concentration of skilled professionals.
The expansion comes at a time when global companies are reassessing how they organise innovation and enterprise support. Many are choosing India not only for technology talent but also for domain expertise, leadership depth and the ability to manage complex global functions from a single hub. This has helped Indian GCCs move closer to core business strategy.
Industry experts note that the growth of healthcare and life sciences GCCs could also create opportunities for AI specialists, data scientists, product managers, regulatory professionals and digital transformation leaders. As companies modernise research, operations and customer-facing systems, demand for cross-functional talent is expected to rise.
For marketers and business teams, the rise of such centres is also significant. GCCs increasingly support digital commerce, customer intelligence, analytics, brand operations and enterprise technology platforms that influence how companies engage with customers and partners globally. It also signals continued confidence in India’s specialised healthcare technology workforce.
Merck’s latest Bengaluru investment reinforces the steady shift in India’s GCC landscape from service delivery to innovation-led global ownership. As science and technology companies deepen their presence in the country, India is expected to play a larger role in shaping digital, research and business transformation agendas for multinational enterprises.